Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [22]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 17692-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#17692-1-AP, RRID:AB_2146624
- Product name
- MYOM3 antibody
- Antibody type
- Polyclonal
- Description
- MYOM3 antibody (Cat. #17692-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Improving angiogenesis ameliorates the efficacy of ASO-based exon skipping for the treatment of Duchenne muscular dystrophy.
A new dystrophin-deficient rat model mirroring exon skipping in patients with DMD exon 45 deletions.
Combined 20-Hydroxyecdysone and Antisense-Mediated Exon Skipping Improve Functional Outcomes in a Mouse Model of Duchenne Muscular Dystrophy.
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy.
Valproic Acid Improves Antisense-Mediated Exon-Skipping Efficacy in mdx Mice.
Extensive striated muscle damage in a rat model of Duchenne muscular dystrophy with Dmd exons 10-17 duplication.
Upregulation of FAM129B protects against glucocorticoid-induced skeletal muscle atrophy via regulating long non-coding RNA NEAT1.
Evaluation of a six-minute walk test in the DE50-MD canine model of Duchenne muscular dystrophy and its effect on blood-borne biomarkers.
In Silico Structural Prediction for the Generation of Novel Performant Midi-Dystrophins Based on Intein-Mediated Dual AAV Approach.
An engineered AAV targeting integrin alpha V beta 6 presents improved myotropism across species.
Identification of disease-specific extracellular vesicle-associated plasma protein biomarkers for Duchenne Muscular Dystrophy and Facioscapulohumeral Muscular Dystrophy.
A functional mini-GDE transgene corrects impairment in models of glycogen storage disease type III.
Palmitic acid conjugation enhances potency of tricyclo-DNA splice switching oligonucleotides.
Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy.
Histone deacetylase inhibitors improve antisense-mediated exon-skipping efficacy in mdx mice.
Longitudinal assessment of blood-borne musculoskeletal disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy.
Changes in Urinary Titin Fragment in Response to Different Types of Dynamic Eccentric Exercises.
An acute eccentric exercise increases circulating myomesin 3 fragments.
Long-Term Efficacy of AAV9-U7snRNA-Mediated Exon 51 Skipping in mdx52 Mice.
A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte Pathology.
Mutant myocilin impacts sarcomere ultrastructure in mouse gastrocnemius muscle.
Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies.
Blitek M, Gastaldi C, Doisy M, Le Coz O, David M, Phongsavanh X, Ben Aicha S, Garcia L, Rotini A, Pagès G, Goyenvalle A
Molecular therapy. Nucleic acids 2026 Mar 12;37(1):102834
Molecular therapy. Nucleic acids 2026 Mar 12;37(1):102834
A new dystrophin-deficient rat model mirroring exon skipping in patients with DMD exon 45 deletions.
Wang T, Daoud C, Dubois A, Corre G, Bellec J, Bovolenta M, Philidet L, Dorval A, Bourg N, Roudaut C, Albini S, Warthi G, Jaber A, Richard I
Disease models & mechanisms 2026 Jan 1;19(1)
Disease models & mechanisms 2026 Jan 1;19(1)
Combined 20-Hydroxyecdysone and Antisense-Mediated Exon Skipping Improve Functional Outcomes in a Mouse Model of Duchenne Muscular Dystrophy.
Blitek M, Gastaldi C, Doisy M, Le Coz O, Tensorer T, Garcia L, Goyenvalle A
Nucleic acid therapeutics 2025;35(2):55-67
Nucleic acid therapeutics 2025;35(2):55-67
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy.
Jaber A, Palmieri L, Bakour R, Bourg N, Hong AV, Lachiver E, Roudaut C, Poupiot J, Albini S, Stockholm D, Van Wittenberghe L, Miranda A, Tanniou G, Danièle N, Barthélémy I, Blot S, Bui MT, Das B, Malfatti E, Evangelista T, Richard I, Israeli D
Science advances 2025 Oct 24;11(43):eadv6805
Science advances 2025 Oct 24;11(43):eadv6805
Valproic Acid Improves Antisense-Mediated Exon-Skipping Efficacy in mdx Mice.
Phongsavanh M, Bizot F, Saoudi A, Gastaldi C, Le Coz O, Tensorer T, Brisebard E, Garcia L, Goyenvalle A
International journal of molecular sciences 2025 Mar 13;26(6)
International journal of molecular sciences 2025 Mar 13;26(6)
Extensive striated muscle damage in a rat model of Duchenne muscular dystrophy with Dmd exons 10-17 duplication.
Masson JD, Taglietti V, Ruby F, Ono H, Mouri N, Jorge A, Guillaud L, Tiret L, Relaix F
Skeletal muscle 2025 Jun 9;15(1):16
Skeletal muscle 2025 Jun 9;15(1):16
Upregulation of FAM129B protects against glucocorticoid-induced skeletal muscle atrophy via regulating long non-coding RNA NEAT1.
Wang Y, Lu Y, Hou J, Wang Y, Luo L, Lu Z, Xie Y, Cai L, Xiao Z
International journal of biological macromolecules 2025 Apr;300:140120
International journal of biological macromolecules 2025 Apr;300:140120
Evaluation of a six-minute walk test in the DE50-MD canine model of Duchenne muscular dystrophy and its effect on blood-borne biomarkers.
Riddell D, Harron R, Hildyard J, Wells D, Piercy R
Wellcome open research 2024;9:681
Wellcome open research 2024;9:681
In Silico Structural Prediction for the Generation of Novel Performant Midi-Dystrophins Based on Intein-Mediated Dual AAV Approach.
Palmieri L, Ferrand M, Vu Hong A, Richard I, Albini S
International journal of molecular sciences 2024 Sep 27;25(19)
International journal of molecular sciences 2024 Sep 27;25(19)
An engineered AAV targeting integrin alpha V beta 6 presents improved myotropism across species.
Vu Hong A, Suel L, Petat E, Dubois A, Le Brun PR, Guerchet N, Veron P, Poupiot J, Richard I
Nature communications 2024 Sep 11;15(1):7965
Nature communications 2024 Sep 11;15(1):7965
Identification of disease-specific extracellular vesicle-associated plasma protein biomarkers for Duchenne Muscular Dystrophy and Facioscapulohumeral Muscular Dystrophy.
Bayazit MB, Henderson D, Nguyen KT, Reátegui E, Tawil R, Flanigan KM, Harper SQ, Saad NY
medRxiv : the preprint server for health sciences 2024 Nov 30;
medRxiv : the preprint server for health sciences 2024 Nov 30;
A functional mini-GDE transgene corrects impairment in models of glycogen storage disease type III.
Gardin A, Rouillon J, Montalvo-Romeral V, Rossiaud L, Vidal P, Launay R, Vie M, Krimi Benchekroun Y, Cosette J, Bertin B, La Bella T, Dubreuil G, Nozi J, Jauze L, Fragnoud R, Daniele N, Van Wittenberghe L, Esque J, André I, Nissan X, Hoch L, Ronzitti G
The Journal of clinical investigation 2024 Jan 16;134(2)
The Journal of clinical investigation 2024 Jan 16;134(2)
Palmitic acid conjugation enhances potency of tricyclo-DNA splice switching oligonucleotides.
Relizani K, Echevarría L, Zarrouki F, Gastaldi C, Dambrune C, Aupy P, Haeberli A, Komisarski M, Tensorer T, Larcher T, Svinartchouk F, Vaillend C, Garcia L, Goyenvalle A
Nucleic acids research 2022 Jan 11;50(1):17-34
Nucleic acids research 2022 Jan 11;50(1):17-34
Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy.
Bourg N, Vu Hong A, Lostal W, Jaber A, Guerchet N, Tanniou G, Bordier F, Bertil-Froidevaux E, Georger C, Daniele N, Richard I, Israeli D
International journal of molecular sciences 2022 Feb 11;23(4)
International journal of molecular sciences 2022 Feb 11;23(4)
Histone deacetylase inhibitors improve antisense-mediated exon-skipping efficacy in mdx mice.
Bizot F, Goossens R, Tensorer T, Dmitriev S, Garcia L, Aartsma-Rus A, Spitali P, Goyenvalle A
Molecular therapy. Nucleic acids 2022 Dec 13;30:606-620
Molecular therapy. Nucleic acids 2022 Dec 13;30:606-620
Longitudinal assessment of blood-borne musculoskeletal disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy.
Riddell DO, Hildyard JCW, Harron RCM, Wells DJ, Piercy RJ
Wellcome open research 2021;6:354
Wellcome open research 2021;6:354
Changes in Urinary Titin Fragment in Response to Different Types of Dynamic Eccentric Exercises.
Lee M, Goral K, Flis D, Skrobot W, Cieminski K, Olek R, Akimoto T, Ziolkowski W
International journal of sports medicine 2021 May;42(5):432-440
International journal of sports medicine 2021 May;42(5):432-440
An acute eccentric exercise increases circulating myomesin 3 fragments.
Lee M, Shin J, Kato T, Kanda K, Oikawa S, Sakuma J, Sugama K, Kawakami Y, Suzuki K, Akimoto T
The journal of physiological sciences : JPS 2021 Jan 19;71(1):4
The journal of physiological sciences : JPS 2021 Jan 19;71(1):4
Long-Term Efficacy of AAV9-U7snRNA-Mediated Exon 51 Skipping in mdx52 Mice.
Aupy P, Zarrouki F, Sandro Q, Gastaldi C, Buclez PO, Mamchaoui K, Garcia L, Vaillend C, Goyenvalle A
Molecular therapy. Methods & clinical development 2020 Jun 12;17:1037-1047
Molecular therapy. Methods & clinical development 2020 Jun 12;17:1037-1047
A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte Pathology.
Birket MJ, Raibaud S, Lettieri M, Adamson AD, Letang V, Cervello P, Redon N, Ret G, Viale S, Wang B, Biton B, Guillemot JC, Mikol V, Leonard JP, Hanley NA, Orsini C, Itier JM
Stem cell reports 2019 Aug 13;13(2):380-393
Stem cell reports 2019 Aug 13;13(2):380-393
Mutant myocilin impacts sarcomere ultrastructure in mouse gastrocnemius muscle.
Lynch JM, Dolman AJ, Guo C, Dolan K, Xiang C, Reda S, Li B, Prasanna G
PloS one 2018;13(11):e0206801
PloS one 2018;13(11):e0206801
Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies.
Rouillon J, Poupiot J, Zocevic A, Amor F, Léger T, Garcia C, Camadro JM, Wong B, Pinilla R, Cosette J, Coenen-Stass AM, Mcclorey G, Roberts TC, Wood MJ, Servais L, Udd B, Voit T, Richard I, Svinartchouk F
Human molecular genetics 2015 Sep 1;24(17):4916-32
Human molecular genetics 2015 Sep 1;24(17):4916-32
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The MYOM3 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human MYOM3. This antibody recognizes human, mouse, rat antigen. The MYOM3 antibody has been validated for the following applications: ELISA, WB analysis.
